Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans (2018)
Attributed to:
Future Vaccine Manufacturing Hub: Advancing the manufacture and deployment of cost effective vaccines
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2139/ssrn.3272234
Publication URI: http://dx.doi.org/10.2139/ssrn.3272234
Type: Journal Article/Review
Parent Publication: SSRN Electronic Journal